Delay in appropriate therapy of Legionella pneumonia associated with increased mortality

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 15, Issue 4, 1996, Pages 286-290

  Heath, C H ^a,b   Grove, D I ^a   Looke, D F M ^a,c  

^a QUEEN ELIZABETH HOSPITAL   (Australia)

^b FLINDERS MEDICAL CENTRE   (Australia)

^c PRINCESS ALEXANDRA HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROMYCIN; SERUM ALBUMIN;

ADULT; AGED; ARTICLE; AUSTRALIA; DIASTOLIC BLOOD PRESSURE; FEMALE; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; INFECTION; LEGIONELLA PNEUMOPHILA; LEGIONNAIRE DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PNEUMONIA; PRIORITY JOURNAL; PROGNOSIS; SEROLOGY; TREATMENT OUTCOME;

ADULT; AGED; ANTI-BACTERIAL AGENTS; BLOOD PRESSURE; ERYTHROMYCIN; FEMALE; HUMANS; LEGIONELLA PNEUMOPHILA; LEGIONNAIRES' DISEASE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SERUM ALBUMIN; TIME FACTORS; TREATMENT OUTCOME;

EID: 0029992865     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01695659     Document Type: Article

References (14)

1. Fraser DW, Tsai TR, Orenstein W, Parkin WE, Beecham HJ, Sharrar RG, Harris J, Mallison GF, Martin SM, McDade JE, Shepard CC, Brachman PS, The Field Investigation Team: Legionnaires' disease: description of an epidemic of pneumonia. New England Journal of Medicine 1977, 297: 1189-1197.
2. Pitt JL, Merry DJ, Steele TW: Legionnaires' disease in South Australia: prevalence and diagnosis. Medical Journal of Australia 1980, 1: 365-368.
3. Niederman MS, Bass JB Jr, Campbell GD, Fein AM, Grossman RF, Mandell LA, Marrie TJ, Sarosi GA, Torres A, Yu VL: Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. American Review of Respiratory Disease 1993, 148: 1418-1426.
4. Edelstein PH: Detection of antibodies to Legionella. In: Rose NR, de Macario EC, Fahey JL, Friedman H, Penn GM (ed): Manual of clinical laboratory immunology. American Society for Microbiology, Washington, DC, 1986, p. 459-466.
5. Winslow WE, Steele TW: Indirect immunofluorescent antibody tests with Legionella longbeachae serogroup 1 antigen in confirmed infections. In: Barbaree JM, Breiman RF, Dufour AP (ed): Legionella: current status and emerging perspectives. American Society for Microbiology, Washington, DC, 1993, p. 17-19.
6. Steele TW: Legionella in South Australia. Communicable Diseases Intelligence 1989, 13: 2-3.
7. Yu VL: Legionella pneumophila (Legionnaires' disease). In: Mandell GL, Bennett JE, Dolin R (ed): Principles and practice of infectious diseases. Churchill Livingstone, New York, 1995, p. 2087-2103.
8. Centers for Disease Control. Legionnaires' disease: diagnosis and management. Annals of Internal Medicine 1978, 88: 363-365.
9. Yee YC, Yu VL: Legionella. In: Gorbach SL, Bartlett JG, Blacklow NR (ed): Infectious diseases. Saunders, Philadelphia, 1992, p. 1533-1538.
10. Edelstein PH: Legionnaires' disease. Clinical Infectious Diseases 1993, 16: 741-749.
11. Bernstein MS, Locksley RM: Legionella infections. In: Isselbacher KJ, Braunwald E, Wilson JD, Martin JB, Fauci AS, Kasper DL (ed): Harrison's principles of internal medicine. McGraw-Hill, New York, 1994, p. 654-658.
12. British Thoracic Society Research Committee: Community-acquired pneumonia in adults in British hospitals in 1982-1983: A survey of aetiology, mortality, prognostic factors and outcome. Quarterly Journal of Medicine 1987, 62: 195-220.
13. Campbell DG: Overview of community-acquired pneumonia: prognosis and clinical features. Medical Clinics of North America 1994, 78: 1035-1048.
14. Australian National Antibiotic Guideline Committee: Respiratory tract infections. In: Antibiotic guidelines. Victorian Medical Postgraduate Foundation, Therapeutics Committee on Behalf of the Victorian Drug Usage Advisory Committee, Melbourne, 1994-1995, p. 25-40.